Valiant Organics Ltd

Valiant Organics Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from Wednesday, July 01, 2026, and will remain in effect until 48 hours after the declaration of financial results for the quarter ended June 30, 2026. The measure aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct, restricting access for directors, promoters, designated persons, and their immediate relatives to prevent potential insider trading.

Valiant Organics Ltd issued a corrigendum to its May 19, 2026, communication regarding the cessation of the Company as a partner of Dhanvallabh Ventures LLP (DVLLP). The clarification addresses inconsistencies in the description of the Settlement Amount. The settlement involves DVLLP transferring 18,607,531 equity shares of Valiant Laboratories Limited to the Company, along with a payment of ₹63,434,544 (inclusive of taxes) from the Company to DVLLP for capital contribution adjustments. The transaction is subject to approvals and definitive documents.

Valiant Organics Ltd's Nomination and Remuneration Committee approved the grant of 19,500 employee stock options under the 'Valiant - Employees Stock Option Plan 2022' at an exercise price of ₹10 per option. Each option allows the holder to apply for one equity share of the company with a face value of ₹10. 15,000 options will vest after one year, with the remainder vesting upon achievement of specified performance criteria. The options are exercisable within three years from the vesting date.

Valiant Organics Ltd's board has approved exploring potential restructuring options among the company, its subsidiaries, and associates. The goal is to achieve operational, organizational, and strategic synergies, simplify the holding structure, and pursue commercial objectives. Restructuring may involve amalgamation, merger, demerger, transfer, or reorganization. The company is considering changes to existing economic interests and holding arrangements, subject to approvals. The board will assess outcomes and determine future actions, with disclosures made as required.

Valiant Organics Ltd re-appointed Smt. Ketki D. Visariya as Cost Auditor and M/s. Manish Modi & Associates as Internal Auditor for the financial year 2026-27. The decision was made during a Board of Directors meeting held on May 16, 2026, where the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, were also approved. The board also approved the identification of the Pharma Business as an additional reportable segment.

Valiant Organics Ltd's Board of Directors approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board also re-appointed Smt. Ketki D. Visariya as Cost Auditor and M/s. Manish Modi & Associates as Internal Auditor for FY 2026-27. Additionally, the Pharma Business was identified as an additional reportable segment.

Valiant Organics Ltd. has announced the approval of audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, as per SEBI regulations. The board also approved the identification of the Pharma Business as an additional reportable segment. Re-appointments of the Cost Auditor and Internal Auditor for FY 2026-27 were also approved. The board meeting concluded on May 16, 2026.

Valiant Organics Ltd has scheduled a Board of Directors meeting on May 16, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The trading window remains closed until May 18, 2026.

Valiant Organics Ltd. has launched the 'Saksham Niveshak' campaign, in compliance with the Investor Education and Protection Fund Authority's request, to reach out to shareholders with unpaid or unclaimed dividends. The campaign aims to create awareness among shareholders to update their KYC details and claim any unpaid or unclaimed dividends before they get transferred to the Investor Education and Protection Fund (IEPF). Shareholders are required to update their PAN, nomination details, contact information, bank account details, and specimen signature with the Registrar & Share Transfer Agent, MUFG Intime India Private Limited or their Depository Participants.

Valiant Organics Ltd. has announced the closure of the trading window for dealing in securities of the company. The closure is effective from Wednesday, April 01, 2026, until 48 hours after the declaration of Financial Results for the quarter and year ended March 31, 2026. This decision is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct for the Prevention of Insider Trading. The move is aimed at preventing insider trading and ensuring fair practices in the securities market.